1
|
Zuloaga DG, Lafrican JJ, Zuloaga KL. Androgen regulation of behavioral stress responses and the hypothalamic-pituitary-adrenal axis. Horm Behav 2024; 162:105528. [PMID: 38503191 PMCID: PMC11144109 DOI: 10.1016/j.yhbeh.2024.105528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/11/2023] [Revised: 02/02/2024] [Accepted: 03/06/2024] [Indexed: 03/21/2024]
Abstract
Testosterone is a powerful steroid hormone that can impact the brain and behavior in various ways, including regulating behavioral and neuroendocrine (hypothalamic-pituitary-adrenal (HPA) axis) stress responses. Early in life androgens can act to alter development of brain regions associated with stress regulation, which ultimately impacts the display of stress responses later in life. Adult circulating androgens can also influence the expression of distinct genes and proteins that regulate stress responses. These changes in the brain are hypothesized to underlie the potent effects of androgens in regulating behaviors related to stress and stress-induced activation of the HPA axis. Androgens can induce alterations in these functions through direct binding to the androgen receptor (AR) or following conversion to estrogens and subsequent binding to estrogen receptors including estrogen receptor alpha (ERα), beta (ERβ), and G protein-coupled estrogen receptor 1 (GPER1). In this review, we focus on the role of androgens in regulating behavioral and neuroendocrine stress responses at different stages of the lifespan and the sex hormone receptors involved in regulating these effects. We also review the specific brain regions and cell phenotypes upon which androgens are proposed to act to regulate stress responses with an emphasis on hypothalamic and extended amygdala subregions. This knowledge of androgen effects on these neural systems is critical for understanding how sex hormones regulate stress responses.
Collapse
Affiliation(s)
- Damian G Zuloaga
- Department of Psychology, University at Albany, Albany, NY, USA.
| | | | - Kristen L Zuloaga
- Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY, USA
| |
Collapse
|
2
|
Jung SJ, Park EO, Chae SW, Lee SO, Kwon JW, You JH, Kim YG. Effects of Unripe Black Raspberry Extract Supplementation on Male Climacteric Syndrome and Voiding Dysfunction: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 2023; 15:3313. [PMID: 37571251 PMCID: PMC10421075 DOI: 10.3390/nu15153313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2023] [Revised: 07/19/2023] [Accepted: 07/21/2023] [Indexed: 08/13/2023] Open
Abstract
Male climacteric syndrome (MCS) is a medical condition that can affect middle-aged men whose testosterone levels begin to decline considerably. These symptoms may include fatigue, decreased libido, mood swings, and disturbed sleep. MCS can be managed with lifestyle modifications and testosterone replacement. However, testosterone therapy may cause number of side effects, including an increased risk of cardiovascular issues. This study aims to evaluate the efficacy and safety of unripe black raspberry extract (BRE) against MCS and voiding dysfunction in men with andropause symptoms. A total of 30 subjects were enrolled and randomly assigned to the BRE group (n = 15) or the placebo group (n = 15). Participants were supplemented with 4800 mg BRE or placebo twice daily for 12 weeks. The impact of BRE was assessed using the Aging Male's Symptoms (AMS scale), International Prostate Symptom Score (IPSS) and the IPSS quality of life index (IPSS-QoL). Additionally, male sex hormones, lipid profiles, and anthropometric indices were assessed 6 and 12 weeks after treatment. The AMS scores did not differ significantly between the two groups. In the BRE group, the total IPSS and IPSS-QoL scores decreased significantly after 12 weeks compared to baseline (p < 0.05), but there was no significant difference compared to the placebo group. However, a significant difference was observed in the IPSS voiding symptoms sub-score compared to the placebo group. Furthermore, LDL-C and TC levels were also significantly lower in the BRE group than in the placebo group (p < 0.05). Collectively, the study provides strong evidence supporting the safety of BRE as a functional food and its supplementation potentially enhances lipid metabolism and alleviates MCS and dysuria symptoms, limiting the development of BPH.
Collapse
Affiliation(s)
- Su-Jin Jung
- Clinical Trial Center for Functional Foods, Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea; (S.-J.J.); (E.-O.P.); (S.-W.C.); (S.-O.L.)
- Clinical Trial Center for K-FOOD Microbiome, Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea
- Research Institute of Clinical Medicine, Medical School, Jeonbuk National University, Jeonju 54907, Republic of Korea
| | - Eun-Ock Park
- Clinical Trial Center for Functional Foods, Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea; (S.-J.J.); (E.-O.P.); (S.-W.C.); (S.-O.L.)
- Clinical Trial Center for K-FOOD Microbiome, Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea
| | - Soo-Wan Chae
- Clinical Trial Center for Functional Foods, Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea; (S.-J.J.); (E.-O.P.); (S.-W.C.); (S.-O.L.)
- Clinical Trial Center for K-FOOD Microbiome, Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea
- Research Institute of Clinical Medicine, Medical School, Jeonbuk National University, Jeonju 54907, Republic of Korea
| | - Seung-Ok Lee
- Clinical Trial Center for Functional Foods, Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea; (S.-J.J.); (E.-O.P.); (S.-W.C.); (S.-O.L.)
- Clinical Trial Center for K-FOOD Microbiome, Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea
- Research Institute of Clinical Medicine, Medical School, Jeonbuk National University, Jeonju 54907, Republic of Korea
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical School, Jeonbuk National University, Jeonju 54896, Republic of Korea
| | - Ji-Wung Kwon
- Berry & Bio Food Research Institute, Gochang, Jeonbuk 56417, Republic of Korea;
| | - Jae-Hyung You
- Department of Urology, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea
| | - Young-Gon Kim
- Clinical Trial Center for Functional Foods, Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea; (S.-J.J.); (E.-O.P.); (S.-W.C.); (S.-O.L.)
- Research Institute of Clinical Medicine, Medical School, Jeonbuk National University, Jeonju 54907, Republic of Korea
- Department of Urology, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea
| |
Collapse
|
3
|
Afsharnia E, Pakgohar M, Haghani H, Sarani A, Khosravi S. The severity of hypogonadism symptoms and its risk factors among male employees of Tehran University of Medical Sciences. Aging Male 2020; 23:489-495. [PMID: 30651006 DOI: 10.1080/13685538.2018.1534095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Abstract
OBJECTIVES The current study was conducted to examine the severity of hypogonadism symptoms and their risk factors among the male employees of Tehran University of Medical Sciences (TUMS). METHODS This cross-sectional study was conducted on 80 male employees aged 40-60 years, with hypogonadism, at TUMS. The participants were selected through census sampling. The data collection tools included the demographic questionnaire and the Aging Male Symptoms (AMS) questionnaire. The participants first completed the demographic questionnaire and then the AMS questionnaire. SPSS statistical software version 22 (Chicago, IL) was used to analyze the data, and one-way ANOVA tests, Pearson's correlation coefficient, and stepwise multivariate logistic regression were applied. RESULTS Based on our findings, the mean overall score of hypogonadism symptoms was 41.71 ± 9.20. Based on Pearson's correlation coefficient results, there was a statistically significant association between the severity of hypogonadism symptoms and age (p < .001). Furthermore, there were significant associations between the economic status, cigarette consumption and hours of sleep and the severity of hypogonadism symptoms (p < .001). CONCLUSIONS The current study's results showed that certain factors can affect hypogonadism in males. Thus, it is important to reduce the severity of hypogonadism symptoms and to modify the factors related to this phenomenon.
Collapse
Affiliation(s)
- Elahe Afsharnia
- School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran Sports Medicine Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
- Department of Reproductive Medicine and Geriatric Health, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran
| | - Minoo Pakgohar
- Department of Biostatistics, School of Health, Iran University of Medical Sciences, Tehran, Iran
| | - Hamid Haghani
- School of Medicine, Islamic Azad University of Zahedan, Zahedan, Iran
| | - Asma Sarani
- Department of Community Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| | - Shahla Khosravi
- Department of Community Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
4
|
Inel Manav A, Gözüyeşil E, Yeşilot SB. Evaluating sexual self-consciousness, sexual self-efficacy, and sexual functions of older people. SEXUAL AND RELATIONSHIP THERAPY 2020. [DOI: 10.1080/14681994.2020.1828576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- Ayşe Inel Manav
- Faculty of Health Sciences, Osmaniye Korkut Ata University, Osmaniye, Turkey
| | - Ebru Gözüyeşil
- Faculty of Health Sciences, Çukurova University, Adana, Turkey
| | | |
Collapse
|
5
|
Testosterone prescribing in men with depression and anxiety disorders. Ann Epidemiol 2020; 50:15-19.e8. [DOI: 10.1016/j.annepidem.2020.05.015] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2019] [Revised: 04/29/2020] [Accepted: 05/30/2020] [Indexed: 10/24/2022]
|
6
|
Vieira MDCS, Leitão AE, Vieira G, Moratelli J, Boing L, Seemann T, Guimarães ACDA. Concurrent training protocol for men with androgen deficiency in the aging male: a randomized clinical trial. Aging Male 2018; 21:149-157. [PMID: 29575951 DOI: 10.1080/13685538.2018.1454421] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND The androgen deficiency in the aging male (ADAM) affects physical, sexual, and psychological aspects with characteristics symptoms of middle-aged men. The practice of regular physical activity and physical exercise can attenuate these symptoms. The aim of this randomized clinical trial is to propose a physical exercise protocol based on concurrent training for middle-aged men with ADAM. METHOD Randomized clinical trial with a 6-month intervention will randomly divided into two groups: experimental group (EG) and control group (CG). Four evaluations will be carried out, (1) pre-intervention; (2) in the first month of intervention; (3) in the third month of intervention; (4) post-intervention, evaluating: physical, psychological, sexual, and hormonal aspects. The intervention protocol with concurrent training will have duration of 6 months; frequency of 3 times weekly, with 60 min per session. The two-way ANOVA test will be used for the inter-group and intra-group comparisons with repeated measurements, and also Sydak's comparison test. CONCLUSION This protocol was developed with the intent of easing the symptoms of ADAM. In addition, it is believed that the concurrent training protocol could be capable to recover hormonal, physical, psychological, and sexual aspect of middle-aged men with ADAM.
Collapse
Affiliation(s)
- Melissa de Carvalho Souza Vieira
- a Postgraduate Program in Human Movement, Sciences Center for Health and Sport Sciences , Santa Catarina State University , Florianópolis , Santa Catarina , Brazil
| | - Alice Erwig Leitão
- a Postgraduate Program in Human Movement, Sciences Center for Health and Sport Sciences , Santa Catarina State University , Florianópolis , Santa Catarina , Brazil
| | - Guilherme Vieira
- b Bachelor in Physical Education , Santa Catarina State University , Florianópolis , Santa Catarina , Brazil
| | - Jéssica Moratelli
- a Postgraduate Program in Human Movement, Sciences Center for Health and Sport Sciences , Santa Catarina State University , Florianópolis , Santa Catarina , Brazil
| | - Leonessa Boing
- a Postgraduate Program in Human Movement, Sciences Center for Health and Sport Sciences , Santa Catarina State University , Florianópolis , Santa Catarina , Brazil
| | - Taysi Seemann
- a Postgraduate Program in Human Movement, Sciences Center for Health and Sport Sciences , Santa Catarina State University , Florianópolis , Santa Catarina , Brazil
| | - Adriana Coutinho de Azevedo Guimarães
- a Postgraduate Program in Human Movement, Sciences Center for Health and Sport Sciences , Santa Catarina State University , Florianópolis , Santa Catarina , Brazil
| |
Collapse
|
7
|
Debate position: cognition and mood are not improved in men administered exogenous testosterone therapy. Curr Opin Urol 2018; 27:525-531. [PMID: 28863017 DOI: 10.1097/mou.0000000000000435] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
PURPOSE OF REVIEW The purpose of this article is to provide an overview of the increasing evidence suggesting that exogenous testosterone therapy is not associated with improvements in cognition or mood. This article is part of a series, in this issue, in which authors are assigned opinion pieces on controversial topics pertaining to testosterone replacement. RECENT FINDINGS Testosterone is increasingly being prescribed. Particularly in the setting of recent data suggestive of possible cardiovascular risk associated with its use; a clear understanding of the domains of health that improve with exogenous testosterone use is important. Data on endogenous and exogenous testosterone with cognition and mood are mixed, likely partly related to methodological differences of type of testosterone, patient population, and dosing. SUMMARY Overall, available data are not suggestive of a clear benefit of testosterone supplementation in multiple domains of cognition and in mood. Supraphysiologic testosterone has been associated with adverse psychological outcomes, albeit not uniformly in studies.
Collapse
|
8
|
Dinh KT, Yang DD, Nead KT, Reznor G, Trinh QD, Nguyen PL. Association between androgen deprivation therapy and anxiety among 78 000 patients with localized prostate cancer. Int J Urol 2017; 24:743-748. [DOI: 10.1111/iju.13409] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2017] [Accepted: 06/05/2017] [Indexed: 11/27/2022]
Affiliation(s)
- Kathryn T Dinh
- Department of Medicine; University of Washington; Seattle Washington USA
| | - David D Yang
- Harvard Medical School; Boston Massachusetts USA
| | - Kevin T Nead
- Department of Radiation Oncology; University of Pennsylvania Perelman School of Medicine; Philadelphia Pennsylvania USA
| | - Gally Reznor
- Center for Surgery and Public Health; Brigham and Women's Hospital; Boston Massachusetts USA
| | - Quoc-Dien Trinh
- Harvard Medical School; Boston Massachusetts USA
- Center for Surgery and Public Health; Brigham and Women's Hospital; Boston Massachusetts USA
- Division of Urological Surgery; Brigham and Women's Hospital; Boston Massachusetts USA
| | - Paul L Nguyen
- Harvard Medical School; Boston Massachusetts USA
- Department of Radiation Oncology; Dana-Farber Cancer Institute; Brigham and Women's Hospital; Boston Massachusetts USA
| |
Collapse
|
9
|
Brotto L, Atallah S, Johnson-Agbakwu C, Rosenbaum T, Abdo C, Byers ES, Graham C, Nobre P, Wylie K. Psychological and Interpersonal Dimensions of Sexual Function and Dysfunction. J Sex Med 2016; 13:538-71. [DOI: 10.1016/j.jsxm.2016.01.019] [Citation(s) in RCA: 196] [Impact Index Per Article: 24.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2015] [Revised: 01/16/2016] [Accepted: 01/19/2016] [Indexed: 12/11/2022]
|
10
|
Lee CP, Chen Y, Jiang KH, Chu CL, Hsu SC, Chen JL, Chen CY. The prevalence and correlates of the positive Androgen Deficiency in the Aging Male (ADAM) questionnaire among psychiatric outpatients: a cross-sectional survey of 176 men in a general hospital in Taiwan. Neuropsychiatr Dis Treat 2015; 11:185-9. [PMID: 25653527 PMCID: PMC4309773 DOI: 10.2147/ndt.s75701] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
INTRODUCTION The Androgen Deficiency in the Aging Male (ADAM) questionnaire is widely used to screen for late-onset hypogonadism. The positive response to the ADAM questionnaire (positive ADAM) has been associated with depression and poorer quality of life in a number of studies. It is unclear whether there is any value of the ADAM questionnaire in psychiatric populations. In this study, we aimed to determine the utility of the ADAM questionnaire in a convenient sample of male psychiatric outpatients. METHODS One hundred and seventy-six men (mean age: 54.3 years; standard deviation: 10.7 years; range: 40-80 years) completed the ADAM questionnaire, the Hospital Anxiety and Depression Scale (HADS), and the Aging Males' Symptoms (AMS) scale. Anxiety was defined as a HADS anxiety subscore ≥8; depression as a HADS depression subscore ≥8; and moderate/severe impairment of health-related quality of life (HQoL) as AMS ≥37. ADAM, anxiety, and depression was used to model the moderate/severe impairment of HQoL. RESULTS One hundred and sixty-four (93%) men had positive ADAM. Positive ADAM was associated with a lower body mass index (P<0.05) and moderate/severe impairment of HQoL (P<0.001), but was not associated with anxiety or depression (P>0.05). Positive ADAM was associated with five symptoms of the AMS scale: "decline of one's feeling of general well-being", "depressive mood", and three sexual symptoms. In regression analysis, positive ADAM was associated with increased risk of moderate/severe impairment of HQoL (unadjusted odds ratio 20.1, 95% confidence interval 3.77-372, P<0.01), which remained significant with covariates of anxiety and depression (adjusted odds ratio 15.6, 95% confidence interval 2.52-309, P<0.05). CONCLUSION The ADAM questionnaire can be used to screen the sexual symptoms but not depression/anxiety in male psychiatric outpatients. Positive ADAM may indicate moderate/severe impairment of HQoL.
Collapse
Affiliation(s)
- Chin-Pang Lee
- Department of Psychiatry, Chang Gung Memorial Hospital, Linkou, Taiwan, Taiwan ; Men's Health Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Taiwan
| | - Yu Chen
- Men's Health Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Taiwan ; Department of Urology, Chang Gung Memorial Hospital, Linkou, Taiwan, Taiwan ; School of Medicine, Chang Gung University, Taoyuan, Taiwan
| | - Kun-Hao Jiang
- Men's Health Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Taiwan ; School of Medicine, Chang Gung University, Taoyuan, Taiwan ; Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan
| | - Chun-Lin Chu
- Department of Psychiatry, Chang Gung Memorial Hospital, Linkou, Taiwan, Taiwan ; Men's Health Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Taiwan ; School of Medicine, Chang Gung University, Taoyuan, Taiwan
| | - Shih-Chieh Hsu
- Department of Psychiatry, Chang Gung Memorial Hospital, Linkou, Taiwan, Taiwan ; Men's Health Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Taiwan ; School of Medicine, Chang Gung University, Taoyuan, Taiwan
| | - Jiun-Liang Chen
- Men's Health Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Taiwan ; School of Medicine, Chang Gung University, Taoyuan, Taiwan ; Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan
| | - Ching-Yen Chen
- Department of Psychiatry, Chang Gung Memorial Hospital, Linkou, Taiwan, Taiwan ; Men's Health Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Taiwan ; School of Medicine, Chang Gung University, Taoyuan, Taiwan
| |
Collapse
|
11
|
Amore M, Innamorati M, Costi S, Sher L, Girardi P, Pompili M. Partial androgen deficiency, depression, and testosterone supplementation in aging men. Int J Endocrinol 2012; 2012:280724. [PMID: 22719760 PMCID: PMC3376477 DOI: 10.1155/2012/280724] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/13/2012] [Revised: 04/08/2012] [Accepted: 04/10/2012] [Indexed: 12/12/2022] Open
Abstract
The aim of this review was to summarize current knowledge on the correlation between depressive symptoms with a syndrome called partial androgen deficiency of the aging male (PADAM) and on the potential benefits of testosterone (T) treatment on mood. Despite, the causative nature of the relationship between low T levels and depression is uncertain, many hypogonadal men suffer from depression and vice versa several depressed patients are affected by hypogonadism. Supplementation with testosterone failed to show sound evidence of effectiveness in the treatment of depression. Nevertheless, testosterone supplementation has proved to be effective on some domains significant for the quality of life of aged patients with PADAM (sexual function and cognitive functions, muscular strengths).
Collapse
Affiliation(s)
- Mario Amore
- Department of Neurosciences, Institute of Psychiatry, University of Parma, Piazza Matteotti 9, 43100 Parma, Italy
- *Mario Amore:
| | - Marco Innamorati
- Department of Neurosciences, Institute of Psychiatry, University of Parma, Piazza Matteotti 9, 43100 Parma, Italy
| | - Sara Costi
- Department of Neurosciences, Institute of Psychiatry, University of Parma, Piazza Matteotti 9, 43100 Parma, Italy
| | - Leo Sher
- Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
| | - Paolo Girardi
- Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy
| | - Maurizio Pompili
- Department of Neurosciences, Mental Health and Sensory Organs, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy
| |
Collapse
|